Business Description
Vext Science Inc
NAICS : 325410
SIC : 3741
ISIN : CA9255401064
Total Employee Number:
173Description
Vext Science Inc engages in the full spectrum of the cannabis product lifecycle, from development and manufacturing to distribution. Its brands include Herbal Wellness, Appalachian Pharm, Revibe, Prism, Vapen, and Firebrand. In Arizona and Ohio, the dispensaries operate under the Herbal Wellness Center brand, while in Ohio the cultivation and manufacturing operations are licensed and branded as Appalachian Pharms Cultivation and Appalachian Pharm Processing. The Company operates through a single operating segment engaged in the cultivation, manufacturing, distribution, and sale of cannabis within the United States. All revenues are generated in the United States.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | 4.08 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 0.44 | |||||
Beneish M-Score | -3.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.1 | |||||
3-Year EBITDA Growth Rate | -41.9 | |||||
3-Year Book Growth Rate | -22.3 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.2 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 14.25 | |||||
9-Day RSI | 17.19 | |||||
14-Day RSI | 20.58 | |||||
3-1 Month Momentum % | -3.14 | |||||
6-1 Month Momentum % | -7.23 | |||||
12-1 Month Momentum % | 55.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.62 | |||||
Quick Ratio | 0.31 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 99.55 | |||||
Days Sales Outstanding | 8.31 | |||||
Days Payable | 50.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.5 | |||||
Shareholder Yield % | 11.03 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 34.03 | |||||
Operating Margin % | -9.27 | |||||
Net Margin % | -30 | |||||
EBITDA Margin % | 16 | |||||
FCF Margin % | 13.65 | |||||
OCF Margin % | 19.75 | |||||
ROE % | -23.99 | |||||
ROA % | -12.27 | |||||
ROIC % | -4.2 | |||||
3-Year ROIIC % | -180.1 | |||||
ROC (Joel Greenblatt) % | -19.36 | |||||
ROCE % | -7.41 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 123 | |||||
Price-to-Owner-Earnings | 3.11 | |||||
PS Ratio | 0.26 | |||||
PB Ratio | 0.76 | |||||
Price-to-Free-Cash-Flow | 2.32 | |||||
Price-to-Operating-Cash-Flow | 1.68 | |||||
EV-to-EBIT | -9.53 | |||||
EV-to-EBITDA | 8.94 | |||||
EV-to-Revenue | 1.43 | |||||
EV-to-Forward-Revenue | 1.5 | |||||
EV-to-FCF | 10.03 | |||||
Price-to-GF-Value | 0.09 | |||||
Price-to-Projected-FCF | 0.06 | |||||
Earnings Yield (Greenblatt) % | -10.5 | |||||
FCF Yield % | 15.67 | |||||
Forward Rate of Return (Yacktman) % | -6.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vext Science Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 44.661 | ||
| EPS (TTM) (€) | -0.052 | ||
| Beta | 0.2712 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.33 | ||
| Volatility % | 82.08 | ||
| 14-Day RSI | 20.58 | ||
| 14-Day ATR (€) | 0.007361 | ||
| 20-Day SMA (€) | 0.13555 | ||
| 12-1 Month Momentum % | 55.56 | ||
| 52-Week Range (€) | 0.087 - 0.222 | ||
| Shares Outstanding (Mil) | 247.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vext Science Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vext Science Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vext Science Inc Frequently Asked Questions
What is Vext Science Inc(FRA:VV5)'s stock price today?
The current price of FRA:VV5 is €0.09. The 52 week high of FRA:VV5 is €0.22 and 52 week low is €0.09.
When is next earnings date of Vext Science Inc(FRA:VV5)?
The next earnings date of Vext Science Inc(FRA:VV5) is .
Does Vext Science Inc(FRA:VV5) pay dividends? If so, how much?
Vext Science Inc(FRA:VV5) does not pay dividend.
Press Release
Articles on Vext Science Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers